Literature DB >> 20577835

CD4-positive diffuse large B cell lymphoma identified by flow cytometry: two case reports.

Marisa Arrondini1, Antonella Barreca, Sabrina Aliberti, Anna Demurtas, Fabrizio Tondat, Domenico Novero, Alessandra Stacchini.   

Abstract

We report two cases of diffuse large B cell lymphoma (DLBCL), both occurring in the small bowel, which coexpress PAX5, weak or no CD20 and the CD4 antigen. The CD4 was initially identified by flow cytometry and then confirmed by immunohistochemistry. CD4 is a representative marker for helper T-lymphocytes and is present on a subset of thymocytes, peripheral T cells and monocytes or macrophages. Unlike CD2 and CD5, no B cell fractions are known to express CD4. It might be hypothesized that the deregulated control of gene expression in malignant B cells, in particular PAX5, leads to the activation of some silent or repressed genes of T cell differentiation. Although lineage infidelity is described in some B lymphomas, it remains as an uncommon phenomenon; to our knowledge, cases reported here are the first two cases of DLBCL of the gastrointestinal tract coexpressing the CD4 antigen to be described to date.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577835     DOI: 10.1007/s12185-010-0631-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  What is anaplastic large cell lymphoma?

Authors:  Metin Ozdemirli; Bruce Cheson; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2004-12       Impact factor: 6.394

2.  ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

Authors:  Kaaren K Reichard; Robert W McKenna; Steven H Kroft
Journal:  Mod Pathol       Date:  2007-02-02       Impact factor: 7.842

Review 3.  Primary mediastinal (thymic) large B cell lymphoma with aberrant expression of CD3: a case report with review of the literature.

Authors:  Endi Wang; Maggie Stoecker
Journal:  Int J Hematol       Date:  2010-02-04       Impact factor: 2.490

4.  Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype.

Authors:  Bruno Petitjean; Fabrice Jardin; Bertrand Joly; Nadine Martin-Garcia; Hervé Tilly; Jean-Michel Picquenot; Josette Brière; Claire Danel; Sylvie Mehaut; Issam Abd-Al-Samad; Christiane Copie-Bergman; Marie-Hélène Delfau-Larue; Philippe Gaulard
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

5.  Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Authors:  Francisco Vega; Chung-Che Chang; Leonard J Medeiros; Mark M Udden; Jeong Hee Cho-Vega; Ching-Ching Lau; Chris J Finch; Regis A Vilchez; David McGregor; Jeffrey L Jorgensen
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

6.  The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.

Authors:  Emina Torlakovic; Goran Torlakovic; Phuong L Nguyen; Richard D Brunning; Jan Delabie
Journal:  Am J Surg Pathol       Date:  2002-10       Impact factor: 6.394

7.  ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.

Authors:  Randy D Gascoyne; Laurence Lamant; Jose I Martin-Subero; Valia S Lestou; Nancy Lee Harris; Hans-Konrad Müller-Hermelink; John F Seymour; Lynda J Campbell; Douglas E Horsman; Isabelle Auvigne; Estelle Espinos; Reiner Siebert; Georges Delsol
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

8.  ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases.

Authors:  Mihaela Onciu; Frederick G Behm; James R Downing; Sheila A Shurtleff; Susana C Raimondi; Zhigui Ma; Stephan W Morris; Wren Kennedy; Sandra C Jones; John T Sandlund
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

9.  Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.

Authors:  Markus Hansson; Mats Jerkeman; Michael Dictor
Journal:  Eur J Haematol       Date:  2007-08       Impact factor: 2.997

Review 10.  Diffuse large B-cell lymphoma with coexpression of CD3 in a pediatric patient: a case report, review of the literature, and tissue microarray study.

Authors:  Jeremy C Wallentine; Sherrie L Perkins; Sheryl R Tripp; Richard D Bruggman; Michael G Bayerl
Journal:  J Pediatr Hematol Oncol       Date:  2009-02       Impact factor: 1.289

View more
  1 in total

Review 1.  CD4-positive diffuse large B-cell lymphoma: A variant with aggressive clinical potential.

Authors:  Mohammad O Hussaini; Friederike H Kreisel; Anjum Hassan; TuDung T Nguyen; John L Frater
Journal:  World J Methodol       Date:  2016-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.